Expand SAGE Menu
SAGE MENU

SAGE Stock Summary and Trading Ideas (Sage Therapeutics | NASDAQ:SAGE)

Charts for Today's Stock Price and Implied Volatility in Sage Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for SAGE by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Sage Therapeutics (SAGE) Frequently Asked Questions

What does Sage Therapeutics do?

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

What symbol and exchange does Sage Therapeutics stock trade?

Sage Therapeutics trades on the NASDAQ stock market under the symbol SAGE.

What is Sage Therapeutics stock price doing today?

As of April 18, 2024, SAGE stock price climbed to $13.27 with 688,932 million shares trading.

What is Sage Therapeutics's Beta?

SAGE has a beta of 1.77, meaning it tends to be more sensitive to market movements. SAGE has a correlation of 0.07 to the broad based SPY ETF.

How much is Sage Therapeutics worth?

SAGE has a market cap of $797.62 million. This is considered a Small Cap stock.

How much money does Sage Therapeutics make?

Last quarter Sage Therapeutics reported $78 million in Revenue and -$.55 earnings per share. This beat revenue expectation by $17 million and exceeded earnings estimates by $.73.

What is the highest and lowest price Sage Therapeutics traded in the last 3 year period?

In the last 3 years, SAGE stock traded as high as $80.87 and as low as $10.92.

What are the top ETFs holding Sage Therapeutics?

The top ETF exchange traded funds that SAGE belongs to (by Net Assets): XBI, VTI, VB, IWM, VXF.

Is Sage Therapeutics (SAGE) a good investment?

SAGE has underperformed the market in the last year with a price return of -71.0% while the SPY ETF gained +22.6%. SAGE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -50.8% and -22.6%, respectively, while the SPY returned +6.4% and -3.6%, respectively.

What is the support and resistance for Sage Therapeutics (SAGE) stock price?

SAGE support price is $12.14 and resistance is $13.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SAGE stock will trade within this expected range on the day.